Allogeneic tumor enhancement by levamisole, a new immunostimulatory compound: Studies on cell-mediated immunity and humoral antibody response
- 31 August 1975
- journal article
- Published by Elsevier in European Journal of Cancer (1965)
- Vol. 11 (8), 537-544
- https://doi.org/10.1016/0014-2964(75)90125-5
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Characterization of the immunostimulants levamisole and tetramisoleEuropean Journal of Cancer (1965), 1975
- On the nature of blocking factors and their lymphoid target cells in an allogeneic tumor systemEuropean Journal of Cancer (1965), 1975
- Facilitation and inhibition of B16 melanoma by BCG in vivo and by lymphoid cells from BCG‐treated mice in vitroInternational Journal of Cancer, 1974
- Restoration of host defense mechanisms in man by levamisoleLife Sciences, 1973
- Regression of polyoma tumor metastasis by combined unblocking and bcg treatment‐correlation with induced alterations in tumor immunity statusInternational Journal of Cancer, 1973
- Autonomy of thymus‐processed lymphocytes (T cells) for their education into cytotoxic cellsEuropean Journal of Immunology, 1972
- Inhibitory effects of BCG on adenovirus tumorigenesis: Dependence on administration scheduleInternational Journal of Cancer, 1972
- Facilitation of Rat Mammary Tumour Growth by BCGNature, 1970
- In vitro Cytotoxic Activity of Thymus Cells sensitized to AlloantigensNature, 1970
- Plaque Formation in Agar by Single Antibody-Producing CellsScience, 1963